Figure 4

Differences in behavioral performance or VNS exposure cannot explain mapping results. (A) There was no difference across groups in average percent correct performance prior to surgery, before treatment, or during the ten treatment sessions, nor did treatment impact percent correct performance in any group. (B) No difference was observed across treatment groups in the average number of training trials performed per session during any epoch, nor did treatment significantly impact the number of trials performed within any treatment group. (C) The total number of rewarded trials did not differ across treatment groups during the Treatment period, indicating that VNS treated rats in both yohimbine- and vehicle-infused groups received equivalent exposure to VNS. Filled circles denote data for individual subjects; error bars denote SEM.